infecti
prion
compris
abnorm
prion
protein
produc
structur
convers
normal
prion
protein
respons
transmiss
spongiform
encephalopathi
includ
creutzfeldtjakob
diseas
human
prion
infecti
agent
possess
genom
pathogen
protein
thought
evok
immun
respons
although
previous
report
interferon
regulatori
factor
like
involv
pathogenesi
prion
diseas
suggest
protect
role
host
innat
immun
respons
mediat
signal
remain
clarifi
investig
reciproc
interact
type
interferon
evok
activ
prion
infect
found
infect
prion
caus
suppress
endogen
interferon
express
convers
treatment
recombin
interferon
ex
vivo
model
abl
inhibit
prion
infect
addit
cell
mice
defici
type
interferon
receptor
subunit
interferon
alphabeta
receptor
exhibit
higher
suscept
infect
moreov
vivo
ex
vivo
prioninfect
model
treatment
select
type
interferon
receptor
agonist
inhibit
prion
invas
prolong
surviv
period
infect
mice
taken
togeth
data
indic
interferon
signal
interfer
prion
propag
interferonstimul
gene
might
play
protect
role
brain
find
may
allow
develop
new
strategi
combat
fatal
diseas
keyword
prion
infect
type
interferon
iifn
innat
immun
system
abbrevi
iifn
type
interferon
irf
interferon
regulatori
factor
mef
mous
embryon
fibroblast
tlr
tolllik
receptor
human
prion
diseas
includ
creutzfeldtjakob
diseas
transmiss
neurodegen
disord
effect
treatment
current
avail
prion
proteinac
infecti
pathogen
distinct
bacteria
virus
accumul
structur
abnorm
prion
protein
prp
sc
caus
patholog
chang
neuron
death
brain
result
rapidli
progress
cognit
disord
prp
sc
highli
enrich
bsheet
secondari
structur
caus
misfold
normal
cellular
prp
prp
c
prusin
weissmann
et
al
widelyaccept
model
molecular
mechan
prion
pathogenesi
follow
express
introduct
prp
sc
pathogen
protein
accumul
neuron
subsequ
variou
inflammatori
respons
occur
induc
neuron
death
tamguney
et
al
aguzzi
et
al
one
patholog
featur
associ
prion
infect
widespread
diffus
gliosi
howev
hostpathogen
interact
diseas
remain
incomplet
understood
viral
bacteri
pathogen
induc
variou
immunolog
respons
host
elimin
foreign
pathogen
bodi
amino
acid
sequenc
prp
sc
ident
prp
c
encod
host
gene
host
immun
system
initi
thought
recogn
prion
pathogen
aguzzi
polymenid
howev
accumul
evid
shown
prion
infect
stimul
pattern
recognit
receptor
prr
relat
molecul
relat
signal
pathway
includ
tolllik
receptor
tlr
interferon
regulatori
factor
irf
cytokin
prinz
et
al
spinner
et
al
bradford
mabbott
ishibashi
et
al
nuvolon
et
al
kang
et
al
also
report
upregul
type
interferon
iifn
variou
cell
type
includ
neuron
play
role
host
defenc
prion
infect
ishibashi
et
al
b
persist
prion
infect
neg
regul
via
suppress
transcript
factor
octamerbind
homma
et
al
prion
also
exhibit
strain
divers
reciproc
interfer
strain
analog
viral
infect
dickinson
et
al
dickinson
et
al
manuelidi
addit
level
interferonstimul
gene
antivir
function
includ
myxoviru
resist
protein
protein
kinas
r
oligoadenyl
synthetas
significantli
elev
clinic
stage
prion
diseas
anim
model
riemer
et
al
baker
et
al
xiang
et
al
stobart
et
al
suggest
innat
immun
protect
host
least
partial
prion
infect
studi
focus
relationship
iifn
prion
diseas
sought
determin
interferonstimul
gene
induc
iifn
signal
play
direct
protect
role
prion
invas
anim
experi
conduct
approv
nagasaki
univers
institut
anim
care
use
committe
iacuc
approv
safeti
committe
recombin
dna
experi
approv
anim
care
follow
nagasaki
univers
guidelin
anim
experiment
anim
j
mice
purchas
slc
japan
mice
overexpress
normal
prp
c
provid
prof
horiuchi
hokkaido
univers
japan
fischer
et
al
interferon
alphabeta
receptor
knockout
mice
provid
prof
taniguchi
dr
k
honda
current
affili
keio
univers
professor
univers
tokyo
japan
muller
et
al
anim
maintain
pathogenfre
environ
temperatur
ae
c
humid
food
autoclav
water
avail
ad
libitum
mice
period
inspect
hantaviru
lymphocyt
choriomening
viru
sendai
viru
parainfluenza
viru
type
pneumonia
viru
mice
rat
coronaviru
mycoplasma
pulmoni
clostridium
piliform
result
consist
neg
polyinosinicpolycytidyl
acid
poli
c
invivogen
pentosan
polysulf
pp
sigmaaldrich
imidazonaphthyridin
structur
formula
trifluoromethyl
imidazo
naphthyridin
bionet
purchas
indic
vendor
recombin
mous
ifnand
b
purchas
calbiochem
merck
mous
monoclon
antibodi
recogn
helix
region
prp
kind
gift
prof
matsuda
hiroshima
univers
miyamoto
et
al
antiprp
polyclon
mous
antiserum
ss
santa
cruz
biotechnolog
monoclon
spibio
antibodi
describ
previous
atarashi
et
al
ishibashi
et
al
ishibashi
et
al
homma
et
al
biolegend
antiifnb
santa
cruz
biotechnolog
antiion
calcium
bind
adaptor
molecul
wako
pure
chemic
industri
ltd
antigli
fibrillari
acid
protein
gfap
dako
antimurin
oligoadenyl
synthetas
santa
cruz
biotechnolog
antiha
invitrogen
bactin
sigma
mous
rat
rabbit
monoclon
antibodi
purchas
commerci
sourc
horseradish
peroxidaseconjug
antigoat
jackson
immunoresearch
laboratori
antirat
cell
signal
technolog
inc
cst
antimous
antirabbit
ge
healthcar
life
scienc
igg
antibodi
use
immunoblot
subclon
primer
use
studi
summar
supplementari
tabl
supplementari
tabl
digest
arbitrari
restrict
enzym
respect
lentivir
selfinactiv
sin
vector
kindli
provid
dr
miyoshi
riken
bioresourc
center
brc
ibaraki
japan
plasmid
code
murin
ifnb
construct
insert
orf
region
digest
nhei
noti
experi
use
plasmid
insert
gene
code
fluoresc
protein
venu
perform
dr
miyawaki
riken
brain
scienc
institut
manufactur
insert
region
punointerferonstimul
respons
element
isr
luc
mammalian
express
puno
vector
invivogen
contain
strong
ubiquit
composit
promot
design
use
pcr
product
amplifi
ptalluc
promega
specif
primer
singleround
pcr
tworound
pcr
supplementari
tabl
pcr
product
insert
pcrtopo
vector
invitrogen
digest
xhoi
nhei
confirm
sequenc
final
punoisreluc
plasmid
construct
insert
purifi
product
orf
region
puno
vector
prepar
mscv
viru
retropack
clontech
cell
contain
moloney
murin
leukemia
viru
momulv
gag
pol
env
virusderiv
gene
transfect
either
larg
plasmid
use
lipofectamin
invitrogen
ad
mm
chloroquin
h
prior
transfect
medium
chang
fresh
growth
medium
h
transfect
cultur
supernat
collect
h
medium
replac
filtrat
mm
cellulos
acet
membran
nalgen
syring
filter
thermo
measur
mscv
viru
titrat
cell
seed
densiti
cell
per
well
plate
grown
humidifi
incub
c
co
overnight
confluenc
cell
treat
serial
dilut
viral
solut
mgml
polybren
incub
h
remain
coloni
well
measur
crystal
violet
stain
select
antibiot
week
prepar
lentiviru
cell
cotransfect
construct
lentivir
packag
vector
sin
vector
plasmid
packag
plasmid
pcaghivgp
vsvgrev
plasmid
pcmvvsvgrsvrev
use
lipofectamin
ltx
invitrogen
h
transfect
cell
ad
mm
forskolin
h
growth
medium
includ
lentiviru
collect
filtrat
mm
cellulos
acet
membran
concentr
lentix
tm
concentr
per
manufactur
instruct
clontech
result
lentiviru
titrat
check
quantit
protein
use
lentix
tm
rapid
titer
kit
clontech
cultur
medium
murin
neuroblastoma
cell
fibroblast
cell
obtain
american
type
cultur
collect
creat
vitro
model
use
cell
persist
infect
prion
cell
overexpress
prp
c
establish
cell
integr
mous
prnp
gene
cell
subject
prion
infect
mouseadapt
l
strain
scrapi
previous
describ
nishida
et
al
ishibashi
et
al
packag
cell
cell
lentivir
vector
system
sin
viru
provid
dr
miyoshi
riken
brc
retropack
cell
clontech
express
viral
envelop
protein
mscv
retrovir
express
system
obtain
commerci
sourc
cell
grown
c
co
dulbeccosmodifi
eagl
medium
dmem
wako
contain
mgl
glucos
heatinactiv
foetal
bovin
serum
fb
unitsml
penicillin
mgml
streptomycin
nacalai
tesqu
prioninfect
noninfect
cell
transfect
ifnb
gene
plasmid
use
fugen
roch
per
manufactur
protocol
grown
plate
day
antiprion
treatment
mgml
pp
caughey
raymond
mgml
antiprp
antibodi
miyamoto
et
al
mm
ad
prioninfect
cell
incub
h
stabl
line
construct
nontag
ifnboverexpress
cell
establish
vitro
scrapi
infect
experi
perform
use
clonal
cell
establish
cell
line
stabli
express
target
protein
plasmid
contain
target
gene
transfect
use
fugen
roch
cell
cell
select
mgml
hygrogold
tm
invivogen
treatment
drugresist
coloni
isol
prepar
primari
mous
embryon
fibroblast
mef
mous
embryo
pregnant
femal
mice
isol
dissect
uterin
horn
day
rins
ethanol
embryo
separ
placenta
brain
intern
organ
remov
place
petri
dish
contain
phosphatebuff
salin
pb
sequenti
tissu
chop
use
razor
blade
suspend
subdivid
trypsinedta
procedur
perform
use
asept
techniqu
biolog
safeti
cabinet
centrifug
collect
cell
resuspend
seed
fresh
dmem
contain
fb
describ
cultur
dish
medium
chang
follow
day
adher
fibroblast
cell
cultur
passag
adequ
cell
volum
achiev
establish
immort
mef
amplifi
fibroblast
mice
subclon
passag
serial
replac
mgml
hygrogold
tm
select
cell
follow
infect
mscvlarg
vector
rate
coloni
form
unit
cfu
per
mm
cultur
dish
geneintroduc
mef
establish
subclon
passag
mgml
puromycin
select
cell
occur
follow
infect
vector
final
concentr
mgml
polybren
rate
cfu
per
mm
cultur
dish
genetransduc
mef
cell
transient
cotransfect
plasmid
punoisreluc
prlnull
intern
standard
plasmid
use
lipofectamin
tm
ltx
cultur
h
treat
cell
continu
transfect
mgml
poli
c
use
lipofectamin
tm
ltx
h
cell
lyse
use
passiv
lysi
buffer
promega
luciferas
activ
detect
dual
report
assay
system
promega
quantifi
use
mithra
luminomet
instrument
berthold
technolog
data
luciferas
activ
normal
valu
coexpress
renilla
activ
previous
describ
homma
et
al
ex
vivo
prion
infect
cell
cultur
cell
infect
l
scrapi
straininfect
brain
homogen
prepar
mice
termin
sick
l
strain
final
concentr
brain
homogen
neuron
cell
cell
brain
homogen
mef
cell
cultur
plate
h
subsequ
grown
scale
cm
flask
confluent
subcultur
dilut
fibroblast
neuron
cell
experi
inhibitori
effect
prion
infect
earli
phase
iifn
mm
treat
cell
incub
h
prion
infect
simultan
recombin
mous
iifn
cultur
fifth
passag
scaleup
poli
c
mgwell
stimuli
transfect
lipofectamin
tm
ltx
incub
h
prion
infect
vivo
prion
infect
male
mice
wildtyp
mice
genet
background
inocul
via
intracerebr
ic
intraperiton
ip
rout
lbrain
homogen
ic
ml
dilut
brain
homogen
ip
ml
dilut
brain
homogen
mice
monitor
everi
day
termin
stage
diseas
clinic
onset
prion
diseas
defin
presenc
two
follow
sign
greasi
andor
yellowish
hair
hunchback
weight
loss
yellow
pubic
hair
atax
gait
nonparallel
hind
limb
prioninfect
mice
sacrif
preclin
onset
day
postinocul
dpi
termin
stage
brain
spleen
remov
right
hemispher
brain
part
spleen
immedi
frozen
homogen
weightvolum
phosphat
buffer
salin
immunoblot
analysi
total
protein
extract
mix
amount
lysi
buffer
describ
remain
tissu
fix
paraformaldehyd
patholog
analysi
perform
neg
control
mock
ageand
strainmatch
mice
inocul
intracerebr
intraperiton
normal
mous
brain
homogen
bioassay
drug
dissolv
pb
includ
kolliphor
hs
basf
one
solvent
use
pharmaceut
applic
fourweekold
ddi
male
mice
purchas
slc
hamamatsu
intracerebr
inocul
ml
dilut
brain
homogen
contain
strain
l
sequenti
mice
intraperiton
administ
mg
drugkgday
everi
day
control
ageand
strainmatch
mice
intraperiton
inocul
solvent
without
drug
vehicl
mice
weigh
three
time
week
moment
onset
termin
stage
diseas
lentivir
vector
intracerebr
stereotax
administ
ipsilater
side
week
intracerebr
inject
l
prion
brain
homogen
inject
mice
volum
lentiviru
via
intracerebr
inject
ml
viral
titer
ifuml
volum
lentiviru
via
stereotax
microinject
ml
viral
titer
ifuml
flow
rate
mlmin
use
automicroinjectorequip
hamilton
syring
seri
narishig
ml
mount
gaug
needl
left
hemispher
brain
thalamu
coordin
mm
anterior
bregma
mm
later
midlin
mm
ventral
form
skull
surfac
lentiviru
code
venu
gene
vector
lvvenu
use
control
confirm
gene
express
lentivir
vector
fluoresc
venu
protein
visual
mice
brain
tissu
week
viral
inocul
use
confoc
laserscan
microscop
lsm
carl
zeiss
nuclei
stain
vectashield
mount
medium
contain
dapi
vector
laboratori
immunoblot
perform
previous
describ
ishibashi
et
al
cultur
cell
anim
tissu
treat
variou
experiment
condit
lyse
lysi
buffer
mm
trishcl
ph
contain
mm
nacl
triton
tm
sodium
deoxychol
mm
edta
proteas
inhibitor
nacalai
tesqu
min
c
lysat
treat
sodium
dodecyl
sulphat
sd
sampl
buffer
separ
sdspolyacrylamid
gel
electrophoresi
blot
polyvinyliden
difluorid
membran
band
detect
appropri
primari
antibodi
horseradish
peroxidaselabel
secondari
antibodi
visual
use
chemilumi
one
l
nacalai
tesqu
ecl
prime
western
blot
detect
kit
ge
healthcar
life
scienc
clariti
tm
western
ecl
substrat
biorad
get
appropri
result
suffici
enzymat
reaction
band
intens
quantifi
use
imagej
softwar
nih
prp
sc
detect
lysat
digest
mg
ml
proteinas
k
nacalai
tesqu
c
min
fluorescenceactiv
cell
sorter
analysi
immort
cell
establish
mous
embryon
fibroblast
mef
cell
reintroduc
mscv
retroviru
code
mous
gene
overexpress
exogen
harvest
pb
contain
mm
edta
cell
suspend
fix
permeabil
bd
cytofix
cytoperm
tm
fixationpermeabil
solut
kit
bd
bioscienc
react
primari
antibodi
alexa
fluor
goat
antirabbit
antimous
igg
molecular
probe
cell
analys
use
flow
cytomet
bd
facscalibur
tm
bd
bioscienc
mice
sacrif
time
point
brain
spleen
tissu
fix
formalin
section
mm
slice
embed
paraffin
evalu
spongiform
chang
section
analys
haematoxylin
eosin
stain
previous
describ
ishibashi
et
al
nakagaki
et
al
per
immunohistochemistri
protocol
deparaffin
rehydr
prepar
prestain
section
boil
target
retriev
solut
dako
treat
hydrogen
peroxidas
methanol
inactiv
endogen
peroxidas
sequenti
incub
bovin
serum
albumin
trisbuff
tbst
room
temperatur
h
section
react
primari
antibodi
envis
polym
horseradish
peroxidaseconjug
antirabbit
antimous
immunoglobulin
g
antibodi
dako
h
c
respect
visual
use
diaminobenzidin
detect
gliosi
wako
microglia
gfap
dako
astrocyt
appli
section
primari
antibodi
prp
sc
stain
autoclav
perform
use
hydrochlor
acid
protocol
describ
previous
nakagaki
et
al
patholog
analysi
brain
tissu
region
cortex
hippocampu
thalamu
cerebellum
pon
evalu
semiquantif
histopatholog
analysi
patholog
degre
region
tissu
score
scale
ie
nondetect
mild
moder
sever
statu
spongiosi
describ
previous
ishibashi
et
al
prion
infect
total
rna
harvest
cell
brain
tissu
use
genelut
tm
mammalian
total
rna
miniprep
kit
sigma
accord
manufactur
protocol
rna
reversetranscrib
superscript
vilo
invitrogen
result
cdna
use
quantit
pcr
reaction
lightcycl
sybr
green
master
roch
appli
scienc
origin
primer
list
measur
light
cycler
instrument
roch
appli
scienc
murin
ncbi
access
number
cdna
amplifi
use
act
gaa
aac
cgt
gga
ctt
sens
primer
agt
cca
tgt
cct
cca
cca
antisens
primer
murin
ncbi
access
number
cdna
use
ggt
atg
ccg
cca
aat
cta
gct
gag
gtc
caa
aat
ttc
murin
ncbi
access
number
cdna
use
agc
ttt
gct
ggg
aac
ttt
gaa
aga
tcg
agc
tgg
gtg
murin
ncbi
access
number
cdna
use
cag
caa
agt
ccc
tga
tga
ca
aga
ggt
ggt
gta
agc
cat
murin
ncbi
access
number
cdna
use
ggt
atg
ccg
cca
aat
cta
gct
gag
gtc
caa
aat
ttc
murin
retino
acidinduc
gene
ncbi
access
number
cdna
use
aag
gct
gat
gag
gat
gat
tgg
ttt
caa
tgg
gct
gtg
murin
melanoma
differentiationassoci
gene
ncbi
access
number
nm
cdna
use
gct
gct
aaa
gac
gga
aat
tct
tgt
cgc
tgt
cat
tga
murin
ifnb
ncbi
access
number
cdna
use
ccc
tat
gga
gat
gac
gga
ctg
tct
gct
ggt
gga
gtt
respect
intern
standard
mous
bactinactb
ncbi
access
number
cdna
sens
primer
aaa
tcg
tgc
gtg
aca
tca
antisens
primer
aag
gaa
ggc
tgg
aaa
aga
use
primer
design
amplifi
orf
region
ifnb
actb
design
amplifi
orf
region
across
intron
result
normal
actb
mrna
level
investig
permeabl
bbb
kit
tm
use
vitro
bloodbrain
barrier
screen
model
h
pharmacocel
co
consist
cocultur
endotheli
cell
pericyt
astrocyt
accord
manufactur
protocol
pervin
et
al
brief
mm
ad
lumin
side
bloodsid
bbb
kit
tm
use
clear
transwel
insert
plate
incub
h
ml
lumin
side
medium
ml
ablumin
side
brainsid
medium
harvest
cultur
plate
concentr
mw
sampl
includ
rest
administ
origin
sampl
measur
use
lipid
chromatographi
tandem
mass
spectrometri
lcm
ms
quantifi
bloodbrain
barrier
permeabl
appar
permeabl
coeffici
papp
cm
calcul
describ
previous
tominaga
et
al
untreat
mice
brain
spleen
dpi
termin
phase
homogen
pb
homogen
sampl
mix
methanol
volum
incub
c
h
standard
sampl
prepar
serial
dilut
nm
compound
mix
normal
brain
homogen
centrifug
min
supernat
sampl
tissu
standard
collect
subject
lcmsm
lcmsm
perform
acquiti
uplci
class
system
coupl
xevo
tm
tq
tripl
quadrupolemass
spectromet
water
uplc
condit
ml
sampl
volum
deliv
acquiti
uplc
beh
column
mm
mm
water
reversedphas
chromatographi
mobil
phase
consist
solvent
mm
ammonium
format
methanol
solvent
b
ultrapur
water
flow
rate
mlmin
c
gradient
elut
solvent
use
order
correspond
ratio
time
point
min
respect
detect
separ
compound
tandem
mass
spectromet
set
esi
posit
ioniz
mode
multipl
reactionmonitor
mrm
mode
collis
energi
cone
voltag
v
v
respect
cone
desolv
ga
flow
rate
desolv
temperatur
set
lh
c
respect
system
tune
monitor
scan
type
mrm
three
channel
set
mz
transit
monitor
rang
precursor
ion
product
ion
mrm
data
concentr
acquir
analysi
masslynx
softwar
water
statist
analysi
data
perform
use
statcel
excel
graphpad
prism
softwar
student
ttest
mannwhitney
utest
use
comparison
two
group
oneway
anova
follow
tukeykram
dunnett
test
multipl
comparison
logrank
test
use
analys
mortal
prioninfect
mice
result
graph
tabl
repres
mean
ae
standard
error
mean
sem
standard
deviat
sd
least
three
independ
experi
author
confirm
data
support
find
studi
avail
within
articl
supplementari
materi
lscrapi
prioninfect
cell
cultur
ex
vivo
model
prion
diseas
tlr
iifn
relat
gene
significantli
downregul
associ
establish
infect
data
repres
prp
sc
express
primari
younger
postnat
day
p
constitut
infect
cell
overexpress
mous
prp
c
immort
mous
fibroblast
cell
fig
c
supplementari
fig
reduct
express
gene
significantli
recov
prp
sc
level
decreas
treatment
pp
caughey
raymond
antiprp
monoclon
antibodi
miyamoto
et
al
see
materi
method
section
fig
supplementari
fig
suggest
prion
infect
might
suppress
sever
innat
immunerel
gene
cultur
cell
iifn
defend
host
infecti
agent
produc
immun
cell
also
cell
type
includ
fibroblast
neuron
delhay
et
al
henc
investig
potenti
antiprion
effect
recombin
iifn
ifnand
b
cell
cultur
model
primari
prionchalleng
test
ifnb
treatment
significantli
suppress
prp
sc
level
persist
lprioninfect
cell
pretreat
cell
becam
resist
lprion
primari
infect
dosedepend
manner
effect
ifnat
similar
dose
weaker
fig
b
similar
resist
prion
also
observ
ifnboverexpress
stabl
cell
line
fig
supplementari
fig
transient
ifnb
express
reduc
endogen
prp
sc
level
persist
l
prioninfect
cell
supplementari
fig
pretransfect
cell
poli
c
activ
innat
immun
system
via
iifn
induct
prevent
establish
prion
infect
dosedepend
manner
fig
evalu
efficaci
ifnb
prion
propag
prion
infecti
anim
model
perform
bioassay
use
lprioninfect
mice
lentiviru
code
ifnb
gene
lvifn
lentivir
vector
administ
week
prion
infect
lvifn
local
thalamu
day
stereotax
inject
mice
brain
fig
lentiviru
carri
mous
ifnb
gene
lvifn
inject
intracerebr
prp
sc
level
significantli
reduc
termin
stage
brain
mice
prion
inocul
fig
patholog
analysi
vacuol
prp
sc
deposit
decreas
significantli
brain
lvifntreat
mice
supplementari
fig
endogen
prp
c
level
chang
respons
ifnb
overexpress
cell
supplementari
fig
indic
ifnb
might
prevent
new
prp
sc
product
earli
phase
primari
prion
infect
without
affect
prp
c
express
confirm
suppress
prion
infect
ifn
associ
ifn
signal
gener
immort
mef
cell
wildtyp
mice
perform
prion
infect
ex
vivo
suscept
l
prion
infect
remark
higher
immort
mef
cell
mice
mef
cell
wildtyp
mice
prion
dosedepend
propag
mef
cell
mef
show
significantli
higher
sensit
prion
infect
lbrain
homogen
mef
wildtyp
fig
next
gener
mef
cell
rescu
deliv
gene
mef
mscv
retrovir
vector
investig
effici
prion
infect
ex
vivo
model
prp
c
level
similar
mef
mef
rescu
deliv
gene
mscv
retrovir
vector
latter
cell
significantli
continu
less
suscept
l
prion
infect
fig
supplementari
fig
b
confirm
whether
transduct
restor
ifn
signal
perform
isrepromot
activ
analysi
use
dual
luciferas
assay
result
indic
promot
activ
mef
poli
c
stimul
significantli
increas
compar
nonstimul
cell
indic
transduc
cell
recov
cell
signal
function
via
wherea
mef
possess
signal
pathway
supplementari
fig
elucid
relationship
iifn
depend
signal
pathway
prion
infect
vivo
inocul
l
prion
wildtyp
mice
monitor
prion
pathogenesi
mice
challeng
intracerebr
dilut
l
prion
brain
homogen
surviv
period
mice
significantli
shorter
ae
day
n
p
logrank
test
wildtyp
mice
ae
day
n
fig
tabl
furthermor
group
mice
inocul
dilut
ic
dilut
ip
also
exhibit
significantli
shorten
surviv
tabl
confirm
pathogenesi
mice
prion
inocul
perform
immunoblot
examin
prp
sc
level
brain
spleen
dpi
termin
stage
prp
sc
level
brain
spleen
mice
similar
wildtyp
mice
fig
supplementari
fig
howev
vacuol
gliosi
microglia
marker
astrocyt
marker
gfap
significantli
sever
wildtyp
mice
addit
accumul
prp
sc
region
dpi
consider
sever
mice
fig
supplementari
fig
taken
togeth
find
indic
iifn
signal
pathway
via
iifn
receptor
includ
protect
degre
prion
infect
c
cell
ex
vivo
prion
infect
lbrain
homogen
bh
preinfect
cell
normal
brain
homogen
treatment
cell
white
lprion
infect
black
immunoblot
show
prp
sc
level
cell
prion
infect
ifnb
level
l
cell
h
pp
treatment
white
l
black
immunoblot
show
prp
sc
level
cell
h
pp
treatment
statist
signific
determin
use
unpair
student
ttest
ac
oneway
anova
follow
tukeykram
test
multipl
comparison
p
p
p
data
present
mean
ae
sem
quantit
rtpcr
western
blot
result
repres
least
three
independ
experi
imidazonaphthyridin
structur
formula
trifluoromethyl
imidazo
naphthyridin
refer
abl
block
hepat
c
viru
infect
sever
cell
includ
cancer
cell
line
human
primari
hepatocyt
report
function
mechan
select
bind
iifn
receptor
sequenti
induct
mani
interferonstimul
gene
follow
activ
iifn
signal
induc
ifnb
lentiviru
system
panel
show
local
lentiviru
thalamu
day
stereotax
inject
mice
brain
venu
green
nuclei
blue
e
scale
bar
mm
prp
sc
level
brain
lprioninfect
mice
termin
stage
brain
preinject
stereotax
st
intracerebr
ic
lvvenu
ifn
f
graph
show
quantif
prp
sc
band
intens
brain
n
mice
per
lentivir
inject
group
statist
signific
determin
use
unpair
student
ttest
c
f
oneway
anova
follow
dunnett
test
multipl
comparison
b
p
p
p
data
present
mean
ae
sem
western
blot
result
repres
least
three
independ
experi
konishi
et
al
determin
whether
ifndepend
signal
mediat
iifn
receptorregul
prion
infect
investig
prp
sc
level
persist
prioninfect
cell
treatment
h
prp
sc
level
l
cell
treat
significantli
reduc
dosedepend
manner
mm
fig
howev
prp
c
level
cell
treat
show
chang
fig
cell
level
oligoadenyl
synthetas
encod
interferonstimul
gene
dosedepend
increas
treatment
moreov
investig
potenti
antiprion
effect
cell
cultur
model
pretreat
cell
becam
resist
lprion
primari
infect
increas
express
dosedepend
manner
fig
suggest
induc
interferonstimul
gene
via
iifn
signal
innat
immun
respons
might
prevent
establish
prion
infect
without
affect
prp
c
express
next
evalu
efficaci
prion
propag
prion
infecti
anim
model
perform
bioassay
use
prioninfect
mice
ddi
mice
intracerebr
inocul
l
prion
brain
homogen
intraperiton
administ
mgkgday
three
time
week
day
postinocul
sacrific
surviv
period
mice
significantli
longer
ae
day
n
p
logrank
test
vehicl
mice
ae
day
n
fig
chang
bodi
weight
group
consist
prolong
surviv
time
chang
bodi
weight
group
gentli
decreas
compar
vehicl
group
delay
week
mice
observ
toxic
due
chronic
administr
symptom
prion
diseas
similar
vehicl
mice
supplementari
fig
analys
prp
sc
histolog
chang
brain
mice
dpi
time
point
diseas
onset
prp
sc
level
brain
spleen
significantli
less
reduct
vehicletr
brain
dpi
prp
sc
suppress
spleen
mice
observ
termin
stage
fig
treatment
significantli
inhibit
level
vacuol
prp
sc
deposit
region
includ
cortex
spleen
compar
vehicl
treatment
dpi
likewis
also
evalu
gliosi
level
brain
mice
dpi
dpi
treatment
significantli
reduc
express
gfap
marker
activ
microglia
astrocyt
multipl
region
cortex
thalamu
pon
howev
treatment
result
chang
express
region
termin
phase
fig
supplementari
fig
result
indic
might
potenti
suppress
prion
format
sever
tissu
bodi
follow
exogen
prion
infect
investig
whether
function
brain
perform
bloodbrain
barrier
permeabl
assay
use
bbb
kit
tm
vitro
bloodbrain
barrier
permeabl
coeffici
papp
indic
abil
compound
transloc
blood
vessel
brain
measur
use
bbb
kit
tm
pervin
et
al
min
exhibit
significantli
higher
bloodbrain
barrier
permeabl
coeffici
ae
sodium
fluorescein
fna
neg
control
ae
fig
moreov
confirm
level
tissu
anim
model
measur
concentr
brain
spleen
prioninfect
mice
treatment
immort
mef
wildtyp
mice
prion
infect
lbrain
homogen
bh
graph
show
quantif
prp
sc
level
wildtyp
black
white
cell
p
versu
wildtyp
b
effici
prion
infect
cell
establish
transduc
gene
immort
mef
immunoblot
show
prp
sc
prion
infect
lbrain
homogen
graph
show
quantif
prp
sc
level
white
black
cell
p
versu
data
present
mean
ae
sem
statist
signific
determin
use
oneway
anova
follow
tukeykram
test
multipl
comparison
unpair
student
ttest
b
dpi
termin
stage
concentr
brain
spleen
cure
mice
dpi
confirm
high
ae
ae
mgg
tissu
respect
concentr
maintain
termin
stage
fig
result
suggest
might
abl
act
specif
brain
spleen
organ
mainli
respons
establish
prion
format
prion
infect
suppress
ifnb
gene
express
lprion
infect
cell
level
ifnb
express
recov
follow
reduct
prp
sc
treatment
antiprion
compound
antibodi
fig
suppress
ifnb
gene
transcript
follow
low
express
via
reduct
prion
figur
gene
deplet
suscept
prion
infect
vivo
anim
model
ad
evalu
prion
pathogenesi
mice
surviv
curv
wildtyp
mice
follow
inocul
intracerebr
ic
dilut
lbrain
homogen
p
logrank
test
prp
sc
level
b
histolog
chang
c
brain
dpi
termin
phase
prion
infect
c
panel
show
vacuol
microglia
astrocyt
gfap
cortex
cx
prp
sc
deposit
cortex
spleen
scale
bar
mm
lesion
profil
vacuol
microgliosi
astrogliosi
prp
sc
deposit
five
brain
region
cortex
hippocampu
hi
thalamu
th
cerebellum
ce
pon
po
detail
lesion
sever
score
histolog
chang
describ
materi
method
section
circl
triangl
symbol
indic
wildtyp
mice
respect
dpi
black
termin
stage
red
p
p
versu
wildtyp
mice
dpi
error
bar
repres
sem
statist
signific
determin
use
unpair
student
ttest
result
repres
least
three
independ
experi
infect
homma
et
al
notabl
rigi
innat
immun
gene
upstream
signal
pathway
relat
iifn
induct
suppress
prion
infect
supplementari
fig
contribut
regul
gene
express
ifnb
also
yount
et
al
heinz
et
al
choi
et
al
farlik
et
al
evok
nfb
activ
intracellular
signal
respons
ifnb
stimuli
moreov
transcript
factor
posit
regul
rigi
express
human
cell
su
et
al
studi
indic
prion
infect
might
result
dysfunct
immun
system
follow
suppress
express
sever
gene
reduct
type
ifn
signal
mediat
close
connect
regul
express
sever
innat
immunityrel
gene
howev
mechan
action
yet
determin
need
investig
futur
although
found
ifn
express
remain
unchang
brain
prioninfect
mice
termin
period
report
express
mani
interferonstimul
gene
increas
brain
prioninfect
anim
riemer
et
al
xiang
et
al
stobart
et
al
similarli
express
sever
interferonstimul
gene
remark
increas
glial
cell
brain
patient
creutzfeldtjakob
diseas
baker
et
al
howev
remain
unclear
whether
ifn
gene
express
increas
ex
vivo
vivo
prioninfect
model
earli
phase
furthermor
determin
whether
ifn
host
play
protect
role
prion
pathogen
infect
experi
prion
infect
suppress
ifn
express
prioninfect
cell
fig
low
ifn
express
level
recov
reduct
prp
sc
fig
furthermor
pretreat
ifn
ifn
system
stimuli
inhibit
new
establish
prion
infect
fig
indic
host
might
combat
prion
propag
use
defenc
system
avail
includ
ifn
thu
necessari
investig
ifn
induct
earli
phase
neuron
prion
infect
iifn
stimul
variou
cell
type
includ
immun
cell
lymphocyt
glia
neuron
delhay
et
al
paul
et
al
intriguingli
iifn
constitut
express
low
level
even
absenc
pathogen
contribut
regul
tumour
propag
cell
growth
taniguchi
takaoka
dysfunct
facilit
prion
pathogenesi
spinner
et
al
ishibashi
et
al
suggest
process
might
neg
regul
signal
pathway
includ
iifn
act
downstream
prr
pretreat
complet
freund
adjuv
unmethyl
cpg
dna
activ
tlr
signal
delay
clinic
onset
mice
prion
inocul
sethi
et
al
tal
et
al
furthermor
glial
cell
pretreat
poli
c
strongli
resist
prion
infect
kang
et
al
posttreat
protect
prion
pathogenesi
mice
worthington
cunningham
et
al
field
et
al
show
iifn
signal
mediat
suppress
prion
pathogenesi
cell
cultur
mous
model
prion
inocul
although
persist
infect
l
prion
decreas
express
innat
immun
gene
ifnb
ex
vivo
system
homma
et
al
iifn
protect
primari
prion
infect
cell
fig
find
suggest
iifn
induc
tlr
signal
exert
crucial
antiprion
effect
earli
phase
prion
infect
tumor
necrosi
factorand
induc
follow
stimul
prr
may
contribut
acceler
prion
infect
determin
prion
bioassay
use
genedefici
mice
thackray
et
al
tamguney
et
al
howev
relationship
suppress
iifn
signal
yet
determin
use
quantit
highthroughput
screen
identifi
novel
small
molecul
act
like
iifn
directli
interact
iifn
receptor
drive
interferonstimul
gene
express
posit
bind
receptor
strongli
evok
ifn
signal
induc
interferonstimul
gene
express
konishi
et
al
thu
markedli
block
hepat
c
viru
replic
cell
death
encephalomyocard
viru
infect
cell
cultur
demonstr
recombin
ifn
treatment
konishi
et
al
wang
et
al
moreov
mice
oral
inocul
show
significantli
higher
express
anim
intracerebr
intraperiton
administr
dilut
brain
homogen
l
prioninfect
termin
mice
p
p
p
sever
interferonstimul
gene
compar
vehicl
group
konishi
et
al
inhibit
prp
sc
prioninfect
cell
chang
prp
c
level
fig
prioninfect
mice
intraperiton
treat
show
significantli
prolong
surviv
period
resist
patholog
chang
brain
prion
infect
fig
sever
low
molecular
weight
compound
npr
provid
stabil
detect
immunoblot
statist
signific
determin
use
oneway
anova
follow
dunnett
test
multipl
comparison
p
p
result
graph
present
mean
ae
sem
least
three
five
independ
experi
protein
structur
bind
prp
c
inhibit
convers
prp
sc
suppress
prion
patholog
prioninfect
mice
follow
intraperiton
chronic
treatment
sever
npr
link
significantli
reduc
prp
sc
level
persist
prioninfect
cell
effect
prp
c
level
ishibashi
et
al
impli
npr
may
show
medic
efficaci
peripher
area
spleen
result
delay
prp
sc
synthesi
accumul
brain
howev
remain
clarifi
whether
npr
act
brain
experi
detect
high
concentr
brain
spleen
prioninfect
mice
dpi
termin
surviv
curv
vehicl
mice
inocul
intracerebr
ic
dilut
lbrain
homogen
p
logrank
test
prp
sc
level
b
histolog
chang
c
brain
cortex
cx
spleen
shown
dpi
termin
phase
prion
infect
lesion
profil
five
brain
region
similar
shown
fig
circl
triangl
symbol
indic
vehicl
mice
respect
dpi
black
termin
stage
red
p
p
versu
vehicl
mice
dpi
error
bar
repres
sem
statist
signific
determin
use
unpair
student
ttest
b
result
repres
least
three
independ
experi
phase
show
high
bloodbrain
barrier
permeabl
vitro
system
compar
control
fig
indic
might
block
prion
propag
act
peripher
tissu
also
brain
furthermor
mice
shorten
life
span
show
chang
phenotyp
rapid
weight
loss
side
effect
continu
treatment
fig
supplementari
fig
suggest
compound
may
safe
clinic
applic
conclus
iifn
pathway
contribut
host
defenc
mechan
prion
infect
although
yet
know
exactli
host
cell
recogn
prion
pathogen
lack
genet
materi
pathway
serv
import
line
defenc
interfer
pathway
permit
persist
prion
infect
reciproc
interact
innat
host
immun
invad
prion
may
explain
long
latenc
prion
diseas
iifn
tlr
signal
divers
function
includ
activ
autophag
system
promot
degrad
synucleinderiv
aggreg
ejlerskov
et
al
kim
et
al
contribut
neuron
homeostasi
taniguchi
takaoka
therefor
effect
iifn
consid
investig
elucid
role
host
immun
prion
diseas
could
facilit
develop
novel
therapeut
deadli
diseas
